Acumen Pharmaceuticals

Acumen Pharmaceuticals

Pharmaceuticals, Charlottesville, Virginia, 22902, United States, 11-50 Employees

acumenpharm.com

  • facebook
  • twitter
  • LinkedIn

phone no Phone Number: 43********

Who is ACUMEN PHARMACEUTICALS

Acumen is forging a new path towards safe and effective treatments for Alzheimers disease and other neurodegenerative diseases through our focus on the biology of toxic soluble amyloid-be...

Read More

map
  • Charlottesville, Virginia, 22902, United States Headquarters: Charlottesville, Virginia, 22902, United States
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $10 Million to $25 Million

industries-icon Industry: Pharmaceuticals

SIC SIC Code: 2836 | NAICS Code: 811212 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from ACUMEN PHARMACEUTICALS

Acumen Pharmaceuticals Org Chart and Mapping

Employees

Adam Mann

Manager, Clinical Trial Supply

Shane Ziemba

Clinical Trial Associate

Jasna Jerecic

Sr. Director Bioanalytical Methods

Andy Gunn

Global Regulatory Affairs

Todd Feaster

Clinical Research Scientist

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Acumen Pharmaceuticals

Answer: Acumen Pharmaceuticals's headquarters are located at Charlottesville, Virginia, 22902, United States

Answer: Acumen Pharmaceuticals's phone number is 43********

Answer: Acumen Pharmaceuticals's official website is https://acumenpharm.com

Answer: Acumen Pharmaceuticals's revenue is $10 Million to $25 Million

Answer: Acumen Pharmaceuticals's SIC: 2836

Answer: Acumen Pharmaceuticals's NAICS: 811212

Answer: Acumen Pharmaceuticals has 11-50 employees

Answer: Acumen Pharmaceuticals is in Pharmaceuticals

Answer: Acumen Pharmaceuticals contact info: Phone number: 43******** Website: https://acumenpharm.com

Answer: Acumen is forging a new path towards safe and effective treatments for Alzheimers disease and other neurodegenerative diseases through our focus on the biology of toxic soluble amyloid-beta oligomers. Our founders pioneered seminal discoveries and methods to understand the role of toxic amyloid-beta oligomers (Ao) in synaptic dysfunction and neurodegeneration. These early insights have fostered decades of research on the biology of Ao at Acumen and throughout the field. We are now on the on cusp of realizing the therapeutic potential of Ao targeted drugs.

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access